Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia)

    January 2001 in “ Dermatologic Surgery
    OʼTAR T. NORWOOD
    Image of study
    TLDR Female pattern alopecia is common, starts in late 20s, and is not androgen dependent.
    The incidence of female androgenetic alopecia, also known as female pattern alopecia, was studied in 1006 Caucasian women aged 20 and above. The study found that female pattern alopecia is quite common, beginning in the late 20s and reaching almost 30% in women over 30 years of age. The study also noted that many women had early type II male androgenetic alopecia, which was not necessarily associated with high levels of testosterone. The study supports the notion that female pattern alopecia is a separate entity from male androgenetic alopecia and is not androgen dependent.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 7 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 6 months ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.

    Related Research

    6 / 6 results